Gemcitabine

Smorenburg, 2001, Eur J Cancer, 37, 2310, 10.1016/S0959-8049(01)00309-4

Simpson, 2004, Drugs, 64, 1839, 10.2165/00003495-200464160-00008

Merriman, 1996, Invest New Drugs, 14, 243, 10.1007/BF00194526

van Moorsel, 2000, Biochim Biophys Acta, 1474, 5, 10.1016/S0304-4165(99)00209-3

Ruiz van Haperen, 1994, Biochem Pharmacol, 48, 1327, 10.1016/0006-2952(94)90554-1

Ruiz van Haperen, 1991, Adv Exp Med Biol, 309A, 57, 10.1007/978-1-4899-2638-8_12

Kroep, 2000, Br J Cancer, 83, 1069, 10.1054/bjoc.2000.1399

Abbruzzese, 1991, J Clin Oncol, 9, 491, 10.1200/JCO.1991.9.3.491

Grunewald, 1991, Cancer Chemother Pharmacol, 27, 258, 10.1007/BF00685109

Shord, 2003, Cancer Chemother Pharmacol, 51, 328, 10.1007/s00280-002-0560-1

Delfino, 2004, Oncology, 66, 18, 10.1159/000076330

Sanchez-Rovira, 1999, Breast Cancer Res Treat, 57, 87

Khoo, 2004, Proc Am Soc Clin Oncol, 23, 54

Vici, 2002, Proc Am Soc Clin Oncol, 21, 61b